Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated a greater reduction in HbA1c (up to 2.4%) than conventional GLP-1 agonists [4]
DEM is a potent activator of Nrf2 transcription factor, the key regulator of the antioxidant response pathway
NAD+: The coenzyme that powers energy, repair, and longevity pathways NAD+ (nicotinamide adenine dinucleotide) is essential for converting food into cellular energy (ATP) and supporting many metabolic reactions
GLP-1 medications work by mimicking the natural GLP-1 hormone, which signals your brain that youre full and slows down digestion
Our paper tried to understand how compounding websites are acting within this landscape of little oversight, and one of the big takeaways is the current landscape allows for free rein of advertising practices, said Ashwin Chetty, an MD candidate and the letters first author
Gastrointestinal adverse effects are among the most commonly reported side effects of GLP-1 therapy, including nausea, vomiting, diarrhoea, and constipation